Russian pharmaceutical serialisation requirements that will take effect in the new year are...
- Personalised cell therapy developer Achilles closes £100m round
- The Ferrari of medical machinery: How one solution impressed Arimpek
- Novartis defends Zolgensma in face of FDA’s data concerns
- Targeting MND-causing genetic mutations to support drug development
- Pharma Technology Focus: the deep dive for new drugs
Sanofi opens digital manufacturing facility in the US
French pharmaceutical giant Sanofi has opened a digital manufacturing facility at Framingham in Massachusetts, the US for continuous production of biologics.
CGT Catapult Manufacturing Facility Expansion
The CGT Catapult Manufacturing Facility, a cell and gene therapy manufacturing facility, in Stevenage in Hertfordshire, UK was expanded in September 2019.
IKA Laboratory Equipment Catalogue
IKA is committed to providing innovations that make your work safer, future-oriented, and smarter. Discover the fascinating world of laboratory equipment and analytical technologies.
Elemental Impurity Analysis in Pharmaceuticals and Implementation of ICH Q3D
Elemental impurities have been a hot topic since 2009 when the International Conference of Harmonisation (ICH) commenced work on a new standard to provide a global policy to limit these impurities in drug products and ingredients.
Avoiding Production Stoppage during Storm Emma
At the beginning of 2018, a leading global pharmaceutical company with two facilities in Ireland, which makes bulk APIs for the global market, was facing several challenges due to adverse weather conditions from Storm Emma.
‘Painful’ 2020 Russian regulations will make EU rules ‘look like a walk in the park’
Russian pharmaceutical serialisation requirements that will take effect in the new year are proving burdensome for manufacturers to implement but experts say the industry can benefit from the infrastructure investment beyond compliance.
CPL: Product Development through Commercialisation
CPL develops and manufactures non-sterile liquid and semi-solid pharmaceutical products. We are solely focused on these dosage forms and have built our reputation as an industry-leading contract development and manufacturing organisation (CDMO).
Gas mixtures for Industrial EO Sterilisation
Ethylene oxide (EO or EtO) cycles are typically based on the control of humidity, flow, pressure, temperature and EO concentration time, the latter of which is an important factor (usually set between 400-800mg / l) and is directly linked to the dwell time, impacting the production cost.
QuVa Pharma’s Pharmaceutical Manufacturing Facility Expansion, New Jersey
QuVa Pharma is expanding its biotech pharmaceutical manufacturing facility in Bloomsbury, New Jersey, US as part of its multi-year growth spree to extend its pharmaceutical facilities beyond Texas.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.